Results 91 to 100 of about 23,004 (191)

Barriers to long‐acting injectable atypical antipsychotic use in Japan: Insights from a comparative psychiatrist survey

open access: yesNeuropsychopharmacology Reports
Aims To investigate the negative attitudes of Japanese psychiatrists toward atypical long‐acting injectable (LAI) antipsychotics, which are the current mainstream LAIs in Japan.
Yoshiyo Oguchi   +2 more
doaj   +1 more source

Reclaiming Pharmacovigilance: Bridging the Evidence–Practice Gap in Psychopharmacology

open access: yes
Journal of Evaluation in Clinical Practice, Volume 32, Issue 2, March 2026.
Carlos De las Cuevas
wiley   +1 more source

Lipid profile in schizophrenic patients on atypical antipsychotics

open access: yesGomal Journal of Medical Sciences, 2012
Background: Atypical antipsychotics are the drugs of first line treatment in schizophrenia because compared to typical antipsychotics, they have minimum extrapyramidal side effects and hence better tolerance by the patients resulting in better compliance.
Faiz ur Rahman   +3 more
doaj  

Atypical Antipsychotics [PDF]

open access: yesPsychiatric Bulletin, 2002
openaire   +2 more sources

Aripiprazole-associated tic in a schizophrenia patient

open access: yesNeuropsychiatric Disease and Treatment, 2015
Xieli Guo,1,2,* Dali Lu,3,* Yugang Jiang1 1Department of Neurosurgery, Second Xiangya Hospital of Central South University, Changsha, Hunan, People’s Republic of China; 2Department of Neurosurgery, Jinjiang Hospital of Quanzhou Medical ...
Guo X, Lu D, Jiang Y
doaj  

Prescribing and deprescribing of atypical antipsychotics in older multimorbid patients. [PDF]

open access: yesBMC Geriatr
Schneider C   +8 more
europepmc   +1 more source

A Meta-Analysis of the Antidepressant Responses in Pivotal Trials on Esketamine Nasal Spray and Atypical Antipsychotics. [PDF]

open access: yesNeuropsychiatr Dis Treat, 2023
Wang L   +9 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy